M19.07
Conditions
Interventions
Group 1: The patient is first contacted and informed about the planned study project. Subsequently, patients are contacted by telephone and asked whether they would like to participate in the study pr
Sponsors
Medizinische Hochschule Hannover
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Performed arthrodesis of at least 2 articular TMT and / or intercuneiform in domo
Exclusion criteria
Exclusion criteria: Younger than 18 years, wheelchair user, further arthrodeses NC / TN / CC / USG / OSG
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| On the basis of the clinical scores (American Orthopaedic Foot and Ankle Society (AOFAS) Score, Foot and Ankle Outcome Score (FAOS), SF-36, University of California at Los Angeles (UCLA) activity scale) and the revision rate, the clinical outcome after Lisfranc arthrodesis is generally to be assessed well. There should be a difference between the pre- and postoperative state. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are differences in clinical and functional outcome with the use of pure screw arthrodesis, additive plate osteosynthesis, or different plate systems, especially with regard to revision / pseudoarthrosis. | — |
Countries
Germany
Contacts
Public ContactSarah Ettinger
Orthopädische Klinik der Medizinischen Hochschule Hannover im Annastift
Outcome results
None listed